ask="2.97"
ask_size="800"
average_daily_volume="413520"
bid="2.30"
bid_size="500"
book_value="3.56"
change="+0.12"
change_from_200_day_moving_average="-1.65"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-6.43"
change_From_52_week_low="0.92"
change_in_percent="+4.29%"
close="2.92"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="N/A"
earnings_per_share="-2.03"
ebitda="-31.76M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-0.80"
ex_dividend_date="N/A"
float_shares="8386000"
high="3.00"
high_52_weeks="9.35"
last_trade_date="3/13/2017"
last_trade_price="2.92"
last_trade_size="1797"
last_trade_time="4:00pm"
low="2.81"
low_52_weeks="2.00"
market_capitalization="45.72M"
moving_average_200_day="4.57"
moving_average_50_day="2.50"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.00"
open="2.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-36.06%"
percent_change_from_50_day_moving_average="+17.01%"
percent_change_from_52_week_high="-68.77%"
percent_change_from_52_week_low="+46.00%"
previous_close="2.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.68"
stock_exchange="NGM"
symbol="NVLS"
volume="376176"
weeks_range_52="2.00 - 9.35"
